Form 4 for SLSN SOLESENCE, INC.
Accepted 2021-11-24 00:00:00 ET · period of report 2021-11-22 · accession 0001209191-21-066811 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-24 | 2021-11-22+ | SLSN | Cureton Kevin | COO | M - OptEx | $0.4541 | +36.4K | 50.4K | +260% | +$16.5K |
| DM | 2021-11-24 | 2021-11-22+ | SLSN | Cureton Kevin | COO | S - Sale+OE | $3.82 | -36.4K | 25.6K | -59% | -$139.0K |
| DM | 2021-11-24 | 2021-11-22+ | SLSN | Cureton Kevin | COO | M - OptEx | $0.4541 | -36.4K | 0 | -100% | -$16.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-22 | M | A | 11,668 | $0.42 | 37,318 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-22 | S | D | 11,668 | $3.92 | 25,650 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-24 | M | A | 12,332 | $0.42 | 37,982 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-24 | M | A | 12,393 | $0.52 | 50,375 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-24 | S | D | 24,725 | $3.77 | 25,650 | D | — | — | |
| 6 | Derivative | Common Stock (right to purchase) | 2021-11-24 | M | D | 12,393 | $0.52 | 62,607 | D | $0.52 · 2015-02-13 to 2024-02-13 | 75,000 Common Stock | (F3) Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| 7 | Derivative | Common Stock (right to purchase) | 2021-11-24 | M | D | 12,332 | $0.42 | 24,000 | D | $0.42 · 2014-02-14 to 2023-02-14 | 36,332 Common Stock | (F2) This line item represents the 2nd sale, of 12,332 shares of a total initial grant of 48,000 shares, leaving a balance of 24,000 shares remaining relating to this grant. (F3) Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| 8 | Derivative | Common Stock (right to purchase) | 2021-11-22 | M | D | 11,668 | $0.42 | 0 | D | $0.42 · 2014-02-14 to 2023-02-14 | 11,668 Common Stock | (F1) This line item represents the 1st sale of 11,668 shares of a total grant of 48,000 shares, leaving a balance of 36,332 shares remaining relating to this grant. |